Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma.
Armand P, Janssens A, Gritti G, Radford J, Timmerman J, Pinto A, Mercadal Vilchez S, Johnson P, Cunningham D, Leonard JP, Rodig SJ, Martín-Regueira P, Sumbul A, Samakoglu S, Tang H, Ansell SM.
Armand P, et al. Among authors: samakoglu s.
Blood. 2021 Feb 4;137(5):637-645. doi: 10.1182/blood.2019004753.
Blood. 2021.
PMID: 32870269
Free PMC article.
Clinical Trial.